MedPath

GLA:D® Back: Patient Education and Exercises for Self-management of Back Pain

Recruiting
Conditions
Back Pain, Low
Registration Number
NCT03570463
Lead Sponsor
University of Southern Denmark
Brief Summary

The GLA:D Back project evaluates the implementation of standardised patient education and exercise therapy for people with persistent or recurrent low back pain (LBP) in a hybrid implementation-effectiveness design. This involves evaluating the process of implementation as well as clinician level outcomes and patient level outcomes.

GLA:D (Good Life with OsteoArthritis in Denmark) is a non-profit initiative and registered trademark from the University of Southern Denmark. It educates clinicians in delivering evidence-based care for musculoskeletal health conditions and registers outcomes in a clinical registry. GLA:D Back uses only the acronym.

The main activity of the implementation strategy is a two-days course for physiotherapists and chiropractors in delivering patient education and exercise therapy that is aimed at supporting patient self-management of LBP. This comes with ready-to-use patient education materials and exercise programs. The course is targeted at chiropractors and physiotherapists, but any health care provider authorised to treat patients with back pain in Denmark can participate, i.e. medical doctors, physiotherapists and chiropractors.

The clinical intervention is a group-based program consisting of two sessions of patient education and 8 weeks of supervised exercises. The program uses a cognitive-behavioural approach and the aim of the exercise component is to restore the patient's ability and confidence to move freely. Clinicians decide which patients are offered the program.

The implementation process is evaluated in a dynamic process monitoring the penetration, adoption and fidelity of the clinical intervention.

The education of clinicians is evaluated via clinician-level outcomes concerning attitudes towards back pain and confidence in managing people with LBP.

The clinical intervention and potential effect mechanisms are evaluated at the patient-level in an observational design. Patients who are participating in the GLA:D Back program are followed using measures of knowledge, skills, beliefs, performance, self-efficacy and success in self-management.

Effects at a national level will be investigated via data from national registries of health care utilisation and sick-leave. Patient- and clinician reported data are collected in a registry.

Detailed Description

The clinician training courses are open to all interested authorised back pain clinicians practicing in Denmark. The study evaluates courses conducted in 2018 which involves one or two courses for clinicians in each of five Danish regions.

The adoption of GLA:D Back is investigated by measuring the extent to which clinicians who have participated in the GLA:D Back course conduct the program in their clinics. Reach of the patient target group is determined by asking clinicians about the degree to which patients offered the treatment accept this. Fidelity with the program is investigated quantitatively by asking about treatment content and recall of key messages via patient questionnaires, and by ensuring that patients' individual goals are registered. The quality of care in terms of delivering the key elements of the intervention will be further explored qualitatively.

The profile of patients enrolled in the GLA:D Back programme will be compared between clinics and administrative regions.

Clinician level effects are investigated in an observational longitudinal design with clinician reported data collected before the clinician training course, immediately after the course and 4 months later, and with patient-reported information on delivery collected at their three-months follow up. Indicators of implementation are registration of patients in the GLA:D Back registry and that patients report receiving the educational components of care and supervised exercises. Orientation towards treatment of LBP and confidence in managing patients with LBP are evaluated by clinicians' answers to standardised questionnaires.

Patient level outcomes are aimed at investigating changes in knowledge, beliefs and skills related to the LBP condition which is hypothesized to lead to improved self-efficacy. The initial measures are related to knowledge skills, beliefs and performance, the next line of outcomes to self-efficacy, then daily activities and quality of life and last health care utilisation and work ability.

The compliance with the program is evaluated by patient report of the number of patient education sessions and exercise sessions attended.

The registry is delivered by Odense Patient data Explorative Network (OPEN) at University of Southern Denmark and uses REDCap (Vanderbilt University) as the platform for data collection. Clinicians are registered when signing up for the GLA:D Back course and agreeing to participate in research. Patients are registered by the clinician and have links to patient questionnaires sent to their email before beginning the GLA:D Back program and after 3, 6 and 12 months if consenting to their data being used for research.

Rather than testing effects on one primary outcome, the study evaluates the implementation process and a number of outcomes based on a logical model of change.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria

The decision to invite a patient to participate in the GLA:D Back program is at the discretion of the clinician. Clinicians are taught that the program was developed for people with persistent or recurrent low back pain and a need for improved self-management

Exclusion Criteria

Back pain related to specific spinal or systemic pathology, signs of acute nerve root involvement

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fear Avoidance Beliefs Questionnaire (FABQ)Change from baseline to 3 months

FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)

The Arthritis Self-efficacy (ASES)Change from baseline to 6 months

ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)

General HealthChange from baseline to 12 months

Health thermometer from Eq-5D, score 0= worst imaginable to 100= best imaginable

Pain medicationDuring 12 months after participation

Prescriptions of pain medication from national registries

Quality of Life (Social functioning)Change from baseline to 12 months

The 36-Item Short Form Health Survey (SF-36) subdomain social functioning, transformed score 0-100

Health care visits primary careDuring 12 months after participation

Number of primary care visits from national registries

Health care visits hospitalDuring 12 months after participation

Number of hospital visits due to LBP from national registries

ImagingDuring 12 months after participation

x-rays, MRI and CT-scans of lower back from national registries

Brief Illness Perceptions Questionnaire (B-IPQ)Change from baseline to 3 months

Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.

Quality of Life (General health)Proportions in response categories baseline to 12 months

The 36-Item Short Form Health Survey (SF-36 item1); 5-point likert scale

Quality of Life (Mental functioning)Change from baseline to 12 months

The 36-Item Short Form Health Survey (SF-36) subdomain mental functioning, transformed score 0-100

Secondary Outcome Measures
NameTimeMethod
Work abilityDuring 12 months after participation

Number of days off work after 1 month of absenteeism available from the 'DREAM' registry from the Danish Ministry of Employment

Patient reported harms or side effects3 months

Text description of any side effects or problems experienced in relation to the participation in GLA:D Back.

Quality of Life (General Health)Proportions in response categories baseline to 3, 6 months

The 36-Item Short Form Health Survey (SF-36 item 1),5-point Likert scale

Satisfaction with care3 months

Overall satisfaction with care (5-point Likert scale; 0 = Not at all satisfied, 5 = Extremely satisfied)

Quality of Life (Social functioning)Change from baseline to 3, 6 months

The 36-Item Short Form Health Survey (SF-36) subdomains social functioning, transformed score 0-100

Confidence with exercisesChange from baseline to 3 months

How confident are you in performing exercises in a beneficial way?' (0-10 scale from 'not confident at all' to 'absolutely confident')

Quality of Life /Mental functioning)Change from baseline to 3, 6 months

The 36-Item Short Form Health Survey (SF-36) subdomains of mental functioning, transformed score 0-100

Oswestry Disability IndexChange from baseline to 3, 6, 12 months

Ten items, sum score 0 - 50 recalculated to 0-100 (0 = No disability; 100 = Maximum disability)

Pain IntensityChange from baseline to 3, 6, 12 months

Numeric Rating Scale 0-10 for typical back pain last week (0 = no pain; 10 = worst imaginable pain)

The Arthritis Self-efficacy (ASES)Change from baseline to 3, 12 months

ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)

Self-assessed physical capacityChange from baseline to 3 months

Self-assessed physical fitness visual analogue scales on perceived strength, endurance, flexibility, balance, and moving unhindered as compared with that of other people of the same age and sex. Each item is scored on a 9-point scale (1 = poor; 5 = average; 9 = super). Each item is treated as one subscale

Brief Illness Perceptions Questionnaire (B-IPQ)Change from baseline to 6, 12 months

Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.

Fear Avoidance Beliefs Questionnaire (FABQ)Change from baseline to 6, 12 months

FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)

Trial Locations

Locations (1)

University of Southern Denmark (central unit)

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath